Clinical Trial Update: A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of paroxetine on the pharmacokinetics of paliperidone ER in schizophrenia, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)
• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED